Traditional drug development in Alzheimer's disease is taking too narrow an approach by focusing intensively on the buildup of amyloid beta-protein in the brain, Dr. Nixon says.
传统的治疗老年痴呆症的药物研发思路仅仅集中在淀粉样β蛋白的累积上，Nixon博士说。
2
We've got a few bugs left to fix and we are still taking feedback from Beta 2 but we're focusing on quality, stability and ensuring TFS works in a wide array of configurations at this point.